National Strategy for Counterterrorism

“The National Strategy for Counterterrorism articulates our government’s approach to countering terrorism and identifies the range of tools critical to this Strategy’s success. U.S. CT efforts require a multidepartmental and multinational effort that goes beyond traditional intelligence, military, and law enforcement functions. This Strategy sets out our overarching goals and the steps necessary to achieve them.”

Author:
U.S. National Security Council
Publish Date:
June 2011

National Terrorism Advisory System (NTAS) Public Guide

The National Terrorism Advisory System, or NTAS, replaces the color-coded Homeland Security Advisory System (HSAS). This new system will more effectively communicate information about terrorist threats by providing timely, detailed information to the public, government agencies, first responders, airports and other transportation hubs, and the private sector. It recognizes that Americans all share responsibility for the nation’s security, and should always be aware of the heightened risk of terrorist attack in the United States and what they should do.

Author:
United States Department of Homeland Security
Publish Date:
April 2011

New Directions: The Ethics of Synthetic Biology and Emerging Technologies

The Presidential Commission for the Study of Bioethical Issues today released its first report—a wide-ranging review of the emerging field of synthetic biology—issuing 18 recommendations including a call for coordinated federal oversight of scientists working in both large institutions and smaller settings.   Read More »

Author:
U.S. Presidential Commission for the Study of Bioethical Issues
Publish Date:
December 2010

NIAID Biodefense Research Agenda for Category B and C Priority Pathogens

In early 2002, NIAID developed a Strategic Plan for Biodefense Research at the National Institute of Allergy and Infectious Diseases (NIAID).  As part of the implementation of the recommendations outlined in the Strategic Plan, NIAID convened two panels of experts to provide advice and guidance on specific areas of research. The first panel prioritized NIAID research plans for the Category A Priority Pathogens. A second group, the NIAID Expert Panel on Immunity and Biodefense, was convened to focus on research related to the innate immune factors important for host protection against potential bioterrorist pathogens (see summary at http://www.niaid.nih.gov/ publications/pdf/biodimmunpan.pdf).   Read More »

Author:
United States Department of Health & Human Services
Publish Date:
January 2003

NIAID Biodefense Research Agenda for CDC Category A Agents

As concern grows about the use of biological agents in acts of terrorism or war, Federal health agencies are evaluating and accelerating measures to protect the public from the health consequences of such an attack. In 1996, when NIAID made public its Research Agenda for Emerging Diseases, intentional introduction of infectious agents was not discussed explicitly. However, recent events have reminded us that bioterrorism can be a major contributor in disease emergence.   Read More »

Author:
United States Department of Health & Human Services
Publish Date:
February 2002